Today, we’d like to introduce you to Eva, a joyful and bright young girl who was hospitalized at the Arabkir Medical Center’s Pediatric Unit in early June 2025 due to breathing difficulties and shortness of breath.
After a series of examinations, she was diagnosed with eosinophilic asthma and eosinophilic pneumonia.
To stabilize her condition and make it manageable, Eva urgently needs to begin treatment with the medication Mepolizumab — one injection every 4 weeks for a period of 3 months.

The full course of medication costs 915,000 AMD — an amount her family cannot afford.

Eva loves going on walks and is especially passionate about football. Her favorite subject at school is biology, and she dreams of becoming a doctor to save lives.

Let’s help Eva overcome this health challenge and take a step closer to making her dream come true.